Skip to main content

Find Clinical Trials

Home
Conditions
Granulomatosis with Polyangiitis

Clinical trial condition

Granulomatosis with Polyangiitis

Explore clinical trials studying Granulomatosis with Polyangiitis. Study availability and eligibility vary by location and protocol.

75 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Granulomatosis with Polyangiitis trial results

Completed

Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography

NCT00001759

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +18 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Treatment of Wegener's Granulomatosis With Cyclophosphamide

NCT00001155

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +18 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis

NCT00001761

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +15 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Diagnostic Effectiveness of Virtual Bronchoscopy

NCT00001515

Conditions: Actinomycetales Infections, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +44 more
Locations: Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States

View Trial Details

Completed

Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions

NCT00001764

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes

NCT00004567

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +16 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Etanercept for Wegener's Granulomatosis

NCT00005007

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations: University of California, San Francisco San Francisco, California, United States

Johns Hopkins University Baltimore, Maryland, United States

Boston University Boston, Massachusetts, United States

University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides

NCT00307593

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +27 more
Locations: Hôpital Cochin Paris, France

View Trial Details

Completed

Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides

NCT00430105

Conditions: ANCA Associated Systemic Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations: Not specified

View Trial Details

Completed

Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.

NCT00138983

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, Arthritis, +32 more
Locations: UMC Utrecht Utrecht, Netherlands

View Trial Details